EMEA-003186-PIP01-22 - paediatric investigation plan

Indapamide

perindopril arginine

Key facts

• Active substance:
  • Indapamide
  • perindopril arginine
• Therapeutic area:
  Cardiovascular diseases
• Decision number:
  P/0212/2022
• PIP number:
  EMEA-003186-PIP01-22
• Pharmaceutical form(s):
  Capsule, hard
• Condition(s) / indication(s):
  Treatment of hypertension
• Route(s) of administration:
  Oral use
• Decision type:
  W: decision granting a waiver in all age groups for all conditions or indications
• Decision date:
  10/06/2022
• Compliance check done:
  No

Decision

P/0212/2022: EMA decision 10 June 2022 on the granting of a product specific waiver for perindopril (arginine) / indapamide (EMEA-003186- PIP01-22)

Adopted Reference Number: EMA/365818/2022